Cardiac Remote Patient Monitoring Devices Market Reaches USD 2.5 Billion in 2026, Driven by the Rising Prevalence of Cardiovascular Diseases and Growing Adoption of Connected Healthcare Solutions

Technological Innovations and Advanced Safety Features to Drive the Automotive Wiper Market to USD 5.54 Billion by 2033, Expanding at a CAGR of 11.7% – Coherent Market Insights

Global Cardiac Remote Patient Monitoring Devices Market, by Application (Cardiac Arrhythmias, Ischemic Diseases, and Hypertension), by End Users (Hospitals, Cardiac Clinics, Ambulatory Surgery Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at USD 2.5 Bn in 2026 and is expected to exhibit a CAGR of 11.7% over the forecast period (2026-2033), as highlighted in a new report published by Coherent Market Insights.

Key players operating in the market are focusing on receiving product approvals from regulatory authorities and this is expected to drive the market growth over the forecast period.

For instance, in July 2021, Abbott Laboratories, introduced the U.S. launch of Jot Dx the organization’s new Insertable cardiac monitor (ICM). It can help in giving the clinicians and hospitals the flow of information by a feature to go through all uncommon heart rhythm details to clarify which irregular heart rhythms are recorded with ‘key episodes’ option.

Browse 20 Market Data Tables and 35 Figures spread through 190 Pages and in-depth TOC on “Global Cardiac Remote Patient Monitoring Devices Market”- Global Forecast to 2033, by Application (Cardiac Arrhythmia, Ischemic Diseases, and Hypertension), by End Users (Hospitals, Cardiac Clinics, Ambulatory Surgery Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/cardiac-remote-patient-monitoring-devices-market-4893

Key players operating in the market are focusing on adoption of inorganic growth strategies such as mergers, launches, collaborations, and acquisitions, in order to strengthen their position in the global market. For instance, in August 2021, Cardiologs, a medical technology company committed to transforming cardiac diagnostics, launched a remote patient monitoring platform created to permit data from smartwatches to be involved in remote arrhythmia monitoring systems. It includes transmit data for patients and cloud-based platform for physician to centralize, simplify the data, as per the press release from the organization.

Key News

• In April 2026, RhythMedix, medical equipment supplier launched its next-generation RhythmStar SL cardiac monitor, designed to improve remote arrhythmia monitoring through greater comfort, wearability, and connectivity. The third-generation wearable features a compact lead configuration, IPX-6 water resistance, longer battery life, and built-in cellular transmission of ECG data to the cloud. Integrated with Augmented Arrhythmia Intelligence, the device supports accurate detection, faster clinical review, improved patient adherence, and streamlined cardiac monitoring workflows for clinicians.
• On February 17, 2026, BIOTRONIK, Medication company partnered with MiCare Path to combine the BIOMONITOR IV insertable cardiac monitor with cellular-enabled blood pressure monitors, weight scales, and a patient mobile application. The integrated solution enables cardiology practices to remotely track arrhythmias, physiological parameters, and changes in cardiac patients’ health conditions. (Source: BIOTRONIK)
• In January 2026, CardioOne, a physician-centric operational and growth partner launched CardioOne Connect, a cloud-based cardiac care platform integrating ambulatory cardiac diagnostics, chronic care management, remote patient monitoring, and cardiac event monitoring. The platform connects with electronic medical records and supports continuous patient-data analysis, proactive monitoring, arrhythmia detection, and coordinated care outside clinical settings.

Key Takeaways of the Global Cardiac Remote Patient Monitoring Devices Market

• Global Cardiac Remote Patient Monitoring Devices Market is expected to exhibit a CAGR of 11.7% over the forecast period, owing to rising launches, agreement and regulatory approvals of products. For instance, in January 2021, Boston Scientific, is a leading innovator of less invasive medical solutions that help people around the world live longer, entered into the agreement to acquire Preventice Solutions, Inc., a privately held organization, which provides full portfolio of cardiac health solutions and facilities.
• Among application, Cardiac Arrhythmia is expected to account for largest market share during the forecast period.
• Major players operating in the global Cardiac Remote Patient Monitoring Devices Market include A & D Medical, BIOTRONIK SE & Co. KG, Boston Scientific, GE Healthcare, Honeywell, Medtronic plc, Nihon Khoden, Philips Healthcare, Spacelabs Healthcare, Abbott Laboratories, St. Jude Medical, VitalConnect Inc., OSYPKA, MeTrax GmbH, and Lepu Medical Technology